CC
NVS icon

Corsicana & Co’s Novartis NVS Stock Holding History

Corsicana & Co’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51K Hold
16
– – ﹤0.01% 286
2026
Q1 		$1.78K Hold
16
– – ﹤0.01% 256
2025
Q4 		$2.21K Hold
16
– – ﹤0.01% 246
2025
Q3 		$2.05K Buy
+16
New +$1.95K ﹤0.01% 247
2022
Q3 		$1K Hold
16
– – ﹤0.01% 199
2022
Q2 		$1K Hold
16
– – ﹤0.01% 204
2022
Q1 		$1K Hold
16
– – ﹤0.01% 206
2021
Q4 		$1K Hold
16
– – ﹤0.01% 205
2021
Q3 		$1K Hold
16
– – ﹤0.01% 207
2021
Q2 		$1K Buy
+16
New +$1.43K ﹤0.01% 200

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Corsicana & Co's NVS Position: Q2 2026 in Review

Corsicana & Co held its Novartis (NVS) position steady in Q2 2026 at 16 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

Corsicana & Co first reported a position in NVS in Q2 2021 and has held it in 10 quarters since. 827 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Corsicana & Co held 16 shares of Novartis worth $2.51K as of Q2 2026.
  • Corsicana & Co left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Corsicana & Co's portfolio in Q2 2026, its #286 holding.
  • Corsicana & Co first reported a position in Novartis in Q2 2021 and has held it in 10 quarters since.
  • 827 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.